Armistice Capital »

Honest shares owned by Armistice Capital

Quarter-by-quarter ownership of Honest (HNST) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Honest

Tip: Access up to 7 years of quarterly data

All positions including Honest held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Honest by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $63k 21k 2.94
2021-12-31 $5.9M 724k 8.09
2021-09-30 $7.2M 692k 10.38

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Honest

BlackRock
Vanguard Group
MAK Capital One
Vanguard Capital Management
Portolan Capital Management
Arrowpoint Asset Management
Geode Capital Management
Citadel Advisors
State Street Corporation
Vanguard Portfolio Management
Dimensional Fund Advisors
AQR Capital Management
Ameriprise Financial
Susquehanna International
Jane Street

View all funds holding Honest